Theravance Biopharma Inc - Company Profile

Powered by

All the data and insights you need on Theravance Biopharma Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Theravance Biopharma Inc Strategy Report

  • Understand Theravance Biopharma Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Theravance Biopharma Inc: Premium Databases

Theravance Biopharma Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Theravance Biopharma Inc’s relevant decision makers and contact details.

A sample of Theravance Biopharma Lead Sheet data

Lead Date Lead Type Lead Description Company Name Drug Name Therapy Area
Showing 3 of 40+ results.
30 Nov 2022 GDCTWXYZ Lorem Lorem Lorem Cardiovascular
25 Nov 2022 Expected Trial Initiations Phase II Trial Initiation Expected on 15-Feb-2023<br/>One quarter of Phase II Trial Initiation for Cardiovascular drugs occur within 3.4 months after positive Phase I Results are announced. Ampreloxetine hydrochloride's Phase II Trial Initiation is estimated to occur 3.4 months from its positive Phase I Results which were announced on November 04, 2022. Theravance Biopharma Inc ampreloxetine hydrochloride Cardiovascular; Gastrointestinal
04 Nov 2022 Trial Results Announced Phase I Trial Result (Other Results) announced on 04-Nov-2022 Theravance Biopharma Inc ampreloxetine hydrochloride Cardiovascular; Gastrointestinal
02 Nov 2022 Trial Results Announced Phase III Trial Result (Other Results) announced on 02-Nov-2022 Theravance Biopharma Inc ampreloxetine hydrochloride Cardiovascular
Lead Sheet

Feature

Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.

  • Lead: Any current or future events that signal a company may need services from another company in the near future.

Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.

Benefit

Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.

Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.

Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.

Value

Lead Sheet is a business development tool to help optimize sales efficiency

  • What prospective accounts to target
  • When and why to target them through actionable leads/opportunities
  • Who to reach out to

Premium databases is part of our industry range of products

Gain a 360-degree view of Theravance Biopharma Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code